Setmelanotide in a Single Patient With Partial Lipodystrophy
Clinical trial NCT03262610 · COMPLETED
Trial details
- NCT number
- NCT03262610
- Sponsor
- Rhythm Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-15
- Primary completion
- 2018-01-31
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.